Intro

This chapter focuses on Kenview’s upcoming public offering as a spinoff from Johnson & Johnson's consumer health division. It examines the implications of this separation for shareholder value and operational efficiency in the consumer health and pharmaceutical sectors.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app